Mucormycosis is a serious but rare fungal infection caused by a group of molds called mucormycetes that has been developing in Covid-19 patients.
The Centre has allocated to states and Union Territories (UTs) 29,250 additional vials of Amphotericin-B, a key drug to treat raging mucormycosis cases in India for the 11,717 patients currently being treated at different hospitals across the country